President Muhammadu Buhari, has given approval to renew the appointment of the Director-General/ Chief Executive Officer of the National Institute for Pharmaceutical Research & Development (NIPRD), Dr. Obi Peter Odigwe, for a second and final term of four (4) years with effect from 10th August, 2022.
The President while congratulating Dr. Odigwe on the re-appointment, charges him to position the institute for effective service delivery to the nation.
